Investigación
Educación
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Neuropsychopharmacology
Christina Henseler has not added Biography.
If you are Christina Henseler and would like to personalize this page please email our Author Liaison for assistance.
Voltage-gated Ca(2+) channel mediated Ca(2+) influx in epileptogenesis.
Advances in experimental medicine and biology , 2012 | Pubmed ID: 22453990
The CaV2.3 R-type voltage-gated Ca2+ channel in mouse sleep architecture.
Sleep May, 2014 | Pubmed ID: 24790266
Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.
Neural plasticity , 2015 | Pubmed ID: 25922768
EEG Radiotelemetry in Small Laboratory Rodents: A Powerful State-of-the Art Approach in Neuropsychiatric, Neurodegenerative, and Epilepsy Research.
Neural plasticity , 2016 | Pubmed ID: 26819775
Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease.
Neural plasticity , 2016 | Pubmed ID: 27840743
Review: Cav2.3 R-type Voltage-Gated Ca(2+) Channels - Functional Implications in Convulsive and Non-convulsive Seizure Activity.
The open neurology journal , 2016 | Pubmed ID: 27843503
Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.
PloS one , 2017 | Pubmed ID: 28072877
Gender specific click and tone burst evoked ABR datasets from mice lacking the Ca2.3 R-type voltage-gated calcium channel.
Data in brief Dec, 2018 | Pubmed ID: 30456242
Gender specific click and tone burst evoked ABR datasets from mice lacking the Ca3.2 T-type voltage-gated calcium channel.
BMC research notes Mar, 2019 | Pubmed ID: 30894204
Ca3.2 T-Type Calcium Channels Are Physiologically Mandatory for the Auditory System.
Neuroscience Apr, 2019 | Pubmed ID: 31029730
Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)
Federal Institute for Drugs and Medical Devices
Anna Papazoglou1,
Andreas Lundt1,
Carola Wormuth1,
Dan Ehninger2,
Christina Henseler1,
Julien Soós1,
Karl Broich1,
Marco Weiergräber1
1Department of Neuropsychopharmacology, Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM),
2Molecular and Cellular Cognition Lab, German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE)
Ralf Müller1,
Anna Papazoglou2,
Julien Soos2,
Andreas Lundt2,
Carola Wormuth2,
Christina Henseler2,
Dan Ehninger3,
Karl Broich4,
Marco Weiergräber2
1Department of Psychiatry and Psychotherapy, University of Cologne,
2Department of Neuropsychopharmacology, Federal Institute for Drugs and Medical Devices,
3Molecular and Cellular Cognition Lab, German Center for Neurodegenerative Diseases,
4, Federal Institute for Drugs and Medical Devices
Andreas Lundt1,2,
Julien Soos1,
Muhammad Imran Arshaad1,
Ralf Müller3,
Dan Ehninger4,
Jürgen Hescheler5,
Agapios Sachinidis5,
Karl Broich6,
Carola Wormuth1,7,
1Experimental Neuropsychopharmacology, Federal Institute for Drugs and Medical Devices,
2, KBRwyle GmbH,
3Cognitive Neurophysiology, Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Cologne,
4Molecular and Cellular Cognition, German Center for Neurodegenerative Diseases (DZNE),
5Institute of Neurophysiology, Faculty of Medicine, University of Cologne,
6, Federal Institute for Drugs and Medical Devices (BfArM),
7, Thescon GmbH
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados